Citation Impact
Citing Papers
Primary Follicular Lymphoma of the Duodenum Is a Distinct Mucosal/Submucosal Variant of Follicular Lymphoma: A Retrospective Study of 63 Cases
2011
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement
2012
Endothelial Progenitor Cells for Vascular Regeneration
2002
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
1998 Standout
Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis
1993
The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry
1996 Standout
Id gene expression during development and molecular cloning of the human Id-1 gene
1995
Southwestern Internal Medicine Conference: Clinical Use of Hematopoietic Growth Factors
1993
Essential role of mouse telomerase in highly proliferative organs
1998 StandoutNatureNobel
Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy.
1993
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
1998 Standout
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
1998
p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time
1994
Monoclonal antibody therapy for B cell non-Hodgkin’s lymphomas: emerging concepts of a tumour-targeted strategy
1999
Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins.
1998
Primed marrow for autologous and allogeneic transplantation: A review comparing primed marrow to mobilized blood and steady-state marrow
2004
Cutaneous Follicle Center Lymphoma: A Clinicopathologic Study of 19 Cases
2001
Role of c-kit/Kit ligand signaling in regulating vasculogenesis
2003
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction
2006 Standout
Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.
1994
Three Different Binding Sites of Cks1 Are Required for p27-Ubiquitin Ligation
2002 StandoutNobel
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
Treatment of Non-Hodgkin's Lymphoma
1993
Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multiple courses of dose-intensive therapy.
1992
Angiogenesis in health and disease
2003 Standout
Role of the retinoblastoma protein in the pathogenesis of human cancer.
1997 StandoutNobel
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
2002 Standout
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.
1992
The pathophysiologic role of alpha 4 integrins in vivo.
1994
Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy
1995
Autologous bone marrow transplantation in adults with non‐Hodgkin's lymphoma: A southwest oncology group study
1994
Hematopoietic Reconstitution in a Patient with Fanconi's Anemia by Means of Umbilical-Cord Blood from an HLA-Identical Sibling
1989 Standout
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study.
1994
Graft-versus-host disease
2009 Standout
Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma.
1994
Long-Term Results of Autologous Stem Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s Lymphoma
2006
One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome.
1993
A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types
1994 StandoutScience
Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study
2016
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2006 Standout
S-Phase Kinase-Associated Protein 2 Expression in Non-Hodgkin's Lymphoma Inversely Correlates with p27 Expression and Defines Cells in S Phase
2002
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk
2003 Standout
Bone Marrow Transplantation
1994
An Olfactory Sensory Map Develops in the Absence of Normal Projection Neurons or GABAergic Interneurons
1998 StandoutNobel
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function
2001 Standout
A review of autologous hematopoietic cell transplantation
2000 Nobel
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
1994 Standout
High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.
1993
Recent advances in the growth and isolation of primitive human haemopoietic progenitor cells
1992
CD34 antigen: Molecular features and potential clinical applications
1993
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
1993 Standout
Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human Cancer
1996
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells
1999 Standout
Symptoms and Suffering at the End of Life in Children with Cancer
2000 Standout
Mammalian G1 cyclins
1993 Standout
Cancer of the Ovary
2004 Standout
High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma.
1994
Prognostic Significance of Ki-67 Nuclear Proliferative Antigen, bcl-2 Protein, and p53 Expression in Follicular and Diffuse Large B-Cell Lymphoma
2001
Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells.
1989
Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow
1994
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
Proliferating dendritic cell progenitors in human blood.
1994 StandoutNobel
Revised Response Criteria for Malignant Lymphoma
2007 Standout
The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
2007 Standout
Effects of Aging and Hypoxia-Inducible Factor-1 Activity on Angiogenic Cell Mobilization and Recovery of Perfusion After Limb Ischemia
2007 StandoutNobel
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Cancer Cell Cycles
1996 StandoutScience
BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration
2000
The rate of telomere sequence loss in human leukocytes varies with age
1998 StandoutNobel
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Cell Cycle Control and Cancer
1994 StandoutScienceNobel
PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma.
1991
Drug Discovery: A Historical Perspective
2000 StandoutScience
Characterization of a candidate bcl-1 gene.
1991
Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma
1994
Retinoblastoma Protein Contains a C-terminal Motif That Targets It for Phosphorylation by Cyclin-cdk Complexes
1999 StandoutNobel
Gene correction in hematopoietic progenitor cells by homologous recombination
2000 StandoutNobel
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
1992 Standout
Granulocyte Colony-Stimulating Factor Reduces the Capacity of Blood Mononuclear Cells to Induce Graft-Versus-Host Disease: Impact on Blood Progenitor Cell Transplantation
1997
Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular Lymphoma
1999
Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach
2005
Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer
1992
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
1997 StandoutScience
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
1999 Standout
Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia
2007
Peripheral blood stem cells reach new heights [editorial; comment]
1993
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma
2001
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Cytokine-induced radiation protection and sensitization
1996
Works of JO Armitage being referenced
Addition of peripheral blood stem cells collected without mobilization techniques to transplanted autologous bone marrow did not hasten marrow recovery following myeloablative therapy.
1991
Chromosomal abnormalities in Hodgkin's disease
1989
Lymphoma classification--the gap between biology and clinical management is closing
1996
Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings
1987
High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma
1989
High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging.
1991
Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents
1992
Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique
1992
Lymphoma classification--the gap between biology and clinical management is closing
1996
Prognostic value of cellular proliferation and histologic grade in follicular lymphoma
1995
Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation
1989
The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies [editorial]
1991
Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy
1988
High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease [published erratum appears in Blood 1991 Dec 15;78(12):3330]
1991
Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up
1992
High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft
1994
Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up
1992
Autologous bone marrow transplantation for patients with aggressive non-Hodgkin's lymphoma.
1992
Chromosomal abnormalities in untreated patients with non-Hodgkin's lymphoma: associations with histology, clinical characteristics, and treatment outcome. The Nebraska Lymphoma Study Group
1990
Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings
1987
Familial haemophagocytic lymphohistiocytosis treated with allogeneic bone marrow transplantation.
1991
Autologous bone marrow transplantation for aggressive non-Hodgkin's lymphoma: issues and controversies.
1991
High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease [published erratum appears in Blood 1991 Dec 15;78(12):3330]
1991
Bone marrow transplantation in the treatment of patients with lymphoma
1989
The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies [editorial]
1991
Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas
1990